# The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man

> **NCT04143750** · PHASE1 · COMPLETED · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 6 (actual)

## Conditions studied

- Healthy Male Adult

## Interventions

- **DRUG:** [14C]Vicagrel

## Key facts

- **NCT ID:** NCT04143750
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-11
- **Primary completion:** 2019-12-29
- **Final completion:** 2020-01-14
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04143750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04143750, "The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04143750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*